ليمفوما هودجكين الكلاسيكية عند الأطفال والمراهقين — المرض المنتكس أو المقاوم

References

• Treatments for Children and Adolescents with Relapsed or Refractory Classical Hodgkin Lymphoma.
• Treatment options for children and adolescents whose disease has relapsed (come back after treatment) or is refractory (did not respond to initial treatment).
• Re-Induction Therapy Options (in alphabetical order): Brentuximab vedotin + bendamustine, Brentuximab vedotin + gemcitabine, Brentuximab vedotin + nivolumab, DHAP (dexamethasone, cytarabine, cisplatin), GV (gemcitabine, vinorelbine), IGEV (ifosfamide, gemcitabine, vinorelbine), IV (ifosfamide, vinorelbine).